HIV-1 protease and reverse transcriptase mutation patterns responsible for discordances between genotypic drug resistance interpretation algorithms

被引:70
作者
Ravela, J
Betts, BJ
Brun-Vézinet, F
Vandamme, AM
Descamps, T
Van Laethem, K
Smith, K
Schapiro, JM
Winslow, DL
Reid, C
Shafer, RW
机构
[1] Stanford Univ, Div Infect Dis, Dept Med, Palo Alto, CA 94301 USA
[2] Hop Bichat Claude Bernard, Virol Lab, F-75877 Paris 18, France
[3] Katholieke Univ Leuven, Rega Inst Med Res, Louvain, Belgium
[4] Visible Genet Inc, Toronto, ON, Canada
关键词
HIV-1; drug resistance; genotype; mutation; reverse transcriptase; protease;
D O I
10.1097/00126334-200305010-00002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Several rules-based algorithms have been developed to interpret results of HIV-1 genotypic resistance tests. To assess the concordance of these algorithms and to identify sequences causing interalgorithm discordances, we applied four publicly available algorithms to the sequences of isolates from 2,045 individuals in northern California. Drug resistance interpretations were classified as S for susceptible, I for intermediate, and R for resistant. Of 30,675 interpretations (2,045 sequences x 15 drugs), 4.4% were completely discordant, with at least one algorithm assigning an S and another an R; 29.2% were partially discordant, with at least one algorithm assigning an S and another an I, or at least one algorithm assigning an I and another an R; and 66.4% displayed complete concordance, with all four algorithms assigning the same interpretation. Discordances between nucleoside reverse transcriptase inhibitor interpretations usually resulted from several simple, frequently occurring mutational patterns. Discordances between protease inhibitor interpretations resulted from a larger number of more complex mutation patterns. Discordances between nonnucleoside reverse transcriptase inhibitor interpretations were uncommon and resulted from a small number of individual drug resistance mutations. Determining the clinical significance of these mutation patterns responsible for interalgorithm discordances will improve interalgorithm concordance and the accuracy of genotypic resistance interpretation.
引用
收藏
页码:8 / 14
页数:7
相关论文
共 12 条
[1]   Human immunodeficiency virus type 1 reverse-transcriptase and protease subtypes: Classification, amino acid mutation patterns, and prevalence in a northern California clinic-based population [J].
Gonzales, MJ ;
Machekano, RN ;
Shafer, RW .
JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (08) :998-1006
[2]   Antiretroviral drug resistance testing in adult HIV-1 infection -: Recommendations of an International AIDS Society-USA panel [J].
Hirsch, MS ;
Brun-Vézinet, F ;
D'Aquila, RT ;
Hammer, SM ;
Johnson, VA ;
Kuritzkes, DR ;
Loveday, C ;
Mellors, JW ;
Clotet, B ;
Conway, B ;
Demeter, LM ;
Vella, S ;
Jacobsen, DM ;
Richman, DD .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (18) :2417-2426
[3]  
Kijak G H, 2003, HIV Med, V4, P72, DOI 10.1046/j.1468-1293.2003.00131.x
[4]   Phenotypic or genotypic resistance testing for choosing antiretroviral therapy after treatment failure:: a randomized trial [J].
Meynard, JL ;
Vray, M ;
Morand-Joubert, L ;
Race, E ;
Descamps, D ;
Peytavin, G ;
Matheron, S ;
Lamotte, C ;
Guiramand, S ;
Costagliola, D ;
Brun-Vézinet, F ;
Clavel, F ;
Girard, PM .
AIDS, 2002, 16 (05) :727-736
[5]   Clinical and laboratory guidelines for the use of HIV-1 drug resistance testing as part of treatment management:: recommendations for the European setting [J].
Miller, V ;
Vandamme, AM ;
Loveday, C ;
Staszewski, S ;
Lundgren, J ;
Youle, M ;
Ait-Khaled, M ;
Boucher, C ;
Brun-Vézinet, F ;
Dedes, N ;
Giaquinto, C ;
Hertogs, K ;
Houyez, F ;
Perrin, L ;
Pillay, D ;
Schmit, JC ;
Schuurman, R ;
Lange, J ;
Bànhegyi, D ;
Biondi, G ;
Broekhuizen, A ;
Bush-Donovan, C ;
Camacho, R ;
Carlier, H ;
Clavel, F ;
Clotet, B ;
Clumeck, N ;
Colebunders, R ;
De Clerq, K ;
De Jaegher, JJ ;
De Schrijver, G ;
De Smet, K ;
Hall, W ;
Harrigan, R ;
Hatzakis, A ;
Hellmann, N ;
Hoetelmans, R ;
Holtzer, C ;
Katlama, C ;
Larder, D ;
Loriaux, E ;
McCreedy, B ;
Mulcahy, F ;
Opravil, M ;
Phillips, A ;
Ruiz, N ;
Shulse, E ;
Sönnerborg, A ;
Soriano, V ;
Steel, H .
AIDS, 2001, 15 (03) :309-320
[6]   Phenotypic and genotypic HIV-1 drug resistance assays provide complementary information [J].
Parkin, N ;
Chappey, C ;
Maroldo, L ;
Bates, M ;
Hellmann, NS ;
Petropoulos, CJ .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 31 (02) :128-136
[7]  
REID C, 2002, ANTIVIR THER, V7, pS91
[8]  
SCHMIDT B, 2001, ANTIVIR THER S, V6, P102
[9]   Human immunodeficiency virus reverse transcriptase and protease sequence database [J].
Shafer, RW ;
Stevenson, D ;
Chan, B .
NUCLEIC ACIDS RESEARCH, 1999, 27 (01) :348-352
[10]   High degree of interlaboratory reproducibility of human immunodeficiency virus type 1 protease and reverse transcriptase sequencing of plasma samples from heavily treated patients [J].
Shafer, RW ;
Hertogs, K ;
Zolopa, AR ;
Warford, A ;
Bloor, S ;
Betts, BJ ;
Merigan, TC ;
Harrigan, R ;
Larder, BA .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (04) :1522-1529